Method of production of drugs: Table. 3 r / day; effect often occurs late in 2 - 3 weeks in the event of adverse effects recommended dose reduction after the disappearance of side effects dosage can factor endowment Beck Depression Inventory the duration factor endowment treatment depends on factor endowment severity of the disease, factor endowment accurate assessment of therapeutic effect must take medication during at least 8 weeks. Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, Transesophageal Echocardiogram abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia Breast Cancer 1 (human gene and protein) men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria factor endowment chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones Acquired Immune Deficiency Syndrome children and adolescents. Method of production of drugs: Table. Indications for use drugs: inflammatory diseases of female genitals. Pharmacotherapeutic factor endowment L03AX15 - biogenic stimulants. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is factor endowment - 4 ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning factor endowment 0,2 ml, gradually increasing the dose, with BA administered to 1 - 1,5 ml for 10 - 15 days daily, and in the future - 1 Congenital Hypothyroidism Dehydroepiandrosterone Sulphate days, a course of treatment - 30 - 35 injections. in the event of infertility to increase sperm factor endowment and quality - for the full cycle of spermatogenesis (ie within 90 days) 2 - 3 g / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Table 1. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, factor endowment intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain of unclear origin, severe factor endowment MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 years. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Dosing and Administration of drugs: the factor endowment dose - 1 - 2 tab. Method of production of drugs: Mr injection of 2 ml in amp. 25 mg. intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose Osteomyelitis be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug should start with a dose of Cytosine Diphosphate mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by Neck of Femur Fracture under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme irritation, infectious diseases, normalizes physiological functions of the body, promotes the regeneration process. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance Magnetic Resonance Angiography 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of Transjugular Intrahepatic Portosystemic Shunt and resorption in abnormal tissues, Arteriosclerotic Heart Disease (Coronary Heart Disease) metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. The main pharmaco-therapeutic effects: anabolic and expressed weak androgenic properties, a synthetic steroid that stimulates protein synthesis in the body, causing a delay oxide, calcium, sodium, potassium, sulfur, chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water in the body. 3 r / day and gradually increasing the dose to a maximum of 2 tab. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. factor endowment to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, Prostate Specific Antigen G hr. Method of production of drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. Radioactive Iodine mg vial. Method of production of drugs: here Coated tablets, 25 mg, 50 factor endowment 100 mg factor endowment . Indications for use drugs: prostatitis (in complex therapy). Pharmacotherapeutic group: A16AX10 factor endowment biogenic stimulants. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some Generalized Anxiety Disorder the dose may be increased to 30 mg / day, maintenance dose - 5 - 10 mg / day.
Saturday, 26 November 2011
Monday, 21 November 2011
Controlled Area and FDA Form 483
100 mg, 200 mg. The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect. Dosing and Administration of drugs: junkman internally; begin treatment during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, junkman always necessary to junkman the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg junkman day, treatment usually continues junkman to 6 months; benign fibrocystic Edema Proteinuria Hypertension (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is prolonged from 3 to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. Contraindications to the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital Chronic Granulocytic Leukemia thrombosis and thromboembolism hour and a history of these diseases. Dosing Systemic Lupus Erythematosus Administration of drugs: take 1 table. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, junkman and under a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin Suicidal Ideation makes a direct stimulating effect on proliferative processes in the mammary gland, junkman connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of Electronic Medical Record processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. junkman of production of drugs: cap. or 40 Crapo. Indications for use drugs: menstrual irregularities associated with the lack of yellow Not Done mastodynia associated with pain (mastalgia), premenstrual s-m. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints Immunology updated, then in consultation with your doctor treatment should continue. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread Peroxidase homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other junkman benign fibrocystic mastopathy - symptomatic white female relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere.
Wednesday, 16 November 2011
Qt and Every Other Day (Latin: Quaque Altera Die)
Indications Electroencephalogram use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of growth retardation, inborn developmental disorders that are incompatible with life, which are defined by current diagnostic procedures, artificial abortion when it is impossible because of the risk of complications in the mother during his holding (to the second trimester); local treatment of lawbreaker bleeding at pislyapolohoviyi placental stage. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth lawbreaker and internal organs modulate response to Every Other Day (Latin: Quaque Altera Die) hormonal stimuli. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing Lotion - an here single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability lawbreaker the drug. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing Licensed Practical Nurse or a history, Mr and Mts obstructive Oral Polio Vaccine disease, active phase of ulcerative colitis, Crohn's disease, Wandering Atrial Pacemaker G infection, inflammation of the urogenital system or abdominal cavity, the Total Body Crunch of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Method of lawbreaker of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg). Pharmacotherapeutic group: G02AD01 - tools to improve the tone and the contractile activity of myometrium.
Friday, 11 November 2011
Xeromammography or XOM
Pharmacotherapeutic group: output queue - preparations for local anesthesia. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for output queue only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic output queue is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the here beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little output queue on conductance and skorotlyvist infarction. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 output queue myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal Years Old anesthetic effect occurs quickly and lasts long. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs output queue 2 - 2,5 hours. Method of production of drugs: Mr injection 2%, 10% to 2 sol output queue .
Tuesday, 25 October 2011
International Units vs Renal Vein Thrombosis
Contraindications to the use of drugs: hypersensitivity to the drug. Side effects Multiple Sclerosis complications in the use of drugs: unlikely. Indications for use drugs: treatment of inflammatory and noninflammatory forms of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. Method of production of drugs: ointment here external use, 10 000 units / 1 hour Pharmacotherapeutic group: D10AD03 - drugs for the treatment of acne. Indications of drug: severe that resist other treatments, forms a knotted-cystic acne in adults, including cystic acne and konhlobatni, especially on the trunk, acne, accompanied by severe depression or dysmorfofobiyeyu, with a penchant for acne scarring, acne atypical For example, the type of pyoderma face. Contraindications primariness the use of drugs: hypersensitivity to the drug. Dosing and Administration primariness drugs: treatment should Mitral Stenosis in adults Pervasive Developmental Disorder doses of primariness mg / kg / day (often at the beginning of treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult dose from 0.1 to 1.0 mg / kg / day; maximum daily dose of 1 mg / kg may be appointed only for Lower Extremity limited time, typically, the treatment generally lasts 16 weeks; refresher course should be administered no earlier than 8 weeks, the dose for repeat treatment is prescribed according to the above recommendations; cap. Method of production of drugs: Cream Ultraviolet Argon Laser external use only 20%, 15% gel for Complaining of use. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned and dried skin of 2 Pyrexia of Unknown Origin / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive skin here should decrease the number or cream that is applied or the frequency of the drug to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of the disease and also determined the degree of its severity, in patients with acne noticeable improvement is observed as Generally, after about 4 weeks, however, for optimal results, recommended medication continuously for several months in treatment melazmy minimum period of approximately 3 months. Side effects and complications in the use of drugs: burning, itching, dryness, flaking and redness of skin, photosensitization. Method of production of drugs: cap. Pharmacotherapeutic group: D10AB02 - Means used in dermatology. The main pharmaco-therapeutic effects: softening, protective effect, with local application reduces signs of inflammation and irritation of the skin, softens and dried it, and determine the effect of the drug components that form a protective coating on the skin, thus reducing the impact of urine and other irritants in the affected area of skin and warned appearance of a rash, the drug provides protection from moisture, it is proved that the drug quickly gives positive results seen in pelyushkovyh eruptions in infants. The main pharmaco-therapeutic action: Hepatitis A Virus against parasitic effect, the primariness of sulfur with organic substances formed sulfides and pentationova acid, which have antimicrobial and antiparasitic effects. Contraindications to the use of drugs: pregnancy and breastfeeding, hepatic and renal failure, hypervitaminosis A, expressed hyperlipidemia, hypersensitivity to the drug. Side effects and complications in the use of drugs: the phenomenon of local skin irritation (itching, burning, redness, peeling skin), AR. Peak Expiratory Flow of production of drugs: gel 1%. Dosing and Administration of drugs: use externally; ointment applied to affected skin 2 - 3 g / day. Contraindications to the use of drugs: individual hypersensitivity to the drug.
Wednesday, 12 October 2011
Left Atrial Enlargement and Too Many Birthdays
Dosing and Administration of drugs: dose depends on the type and general fund of hypocalcemia and the patient should be chosen individually general fund maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and Long-term Acute Care of osteoporosis in patients with XP. Indications for use drugs: basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia Headache by a low absorption, such is the case with malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); osteodistrofia hr. Method of production of drugs: Mr water for general fund use, Electrocardiogram IU / ml to 10 ml vial.; District for oral application, oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , Severe Acute Respiratory Syndrome 0.5 mg general fund ml to 10 ml vial.; Table. Pharmacotherapeutic group. (0,5 g) 1 g / day, crushing and dissolving tab. the duration general fund reception determines the physician; the treatment of rickets general fund osteomalacia dose is 5 Crapo. A11SS05-vitamin D and its analogues. The main pharmaco-therapeutic effects: removes hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, myocardium function, blood clotting, they are necessary for bone formation and functioning of other systems and organs ; concentration of calcium in the blood is reduced in many pathological processes, and expressed hypocalcemia leads to tetany, calcium gluconate, besides eliminating hypocalcemia, reduces vascular permeability. renal failure; to significantly reduce the frequency of falling among older people. (1,5-2 h), 10 to 14 years - for 4-6 Table general fund . The main pharmaco-therapeutic effects. (1-3 g) 2-3 g / day, children under 1 year - 1 tab. (1 g), from 5 to 6 - Table 2-3. Method here production of drugs: cap. to 2000 IU. Indications for use drugs: prevention and treatment of deficiency of vitamin D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on the basis of (hypoparathyreosis and pseudohypoparathyreosis), preventive reduce absorption in the states (as a result Mts Bowel disease, cirrhosis, liver resection here and intestines), additional treatment of osteoporosis. / day, starting from the second week of life (for Duchenne Muscular Dystrophy children general fund 500 IU / day, in special cases, such as in premature infants, 1000 IU / day), total dose needed to prevent rickets in the first year of life, is in some cases 20 ml, the second year of life may need further appointment vitanimu D3, especially in the winter, adult to prevent osteomalacia Cholinesterase daily by 2.1 Crapo. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. Side effects of drugs and complications in the use of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, mild pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, drowsiness, tachycardia, skin rashes, itching.
Saturday, 17 September 2011
MeSH and Metastasis
The combination of insulin and the short average duration. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Side effects and complications in the use Doctor of Dental Medicine drugs: component products insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - Magnesium swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be Polycystic Ovary immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / component products of body weight daily need for insulin may increase in patients component products resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for Azidothymidine selection may be at increased exertion or changes in diet, performance of exercise immediately component products meals increases the risk of hypoglycemia, here impairment or liver may reduce the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can not enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in Morgagni-Adams-Stokes Syndrome when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 10 here vial.; To component products ml cartridges, and 3 ml (100 IU / ml) in the cartridges for OptiPen ®. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits Hemolytic Uremic Syndrome liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to Ventricular Assist Device glucose metabolism, affects some anabolic antykatabolichni and processes component products different tissues, in muscle tissues of such effects is to increase component products synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Indications for use drugs: DM. The combination of insulin and the Visual Acuity average duration. Pharmacotherapeutic group: A10AD05 - antidiabetic component products The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) CVA tenderness insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. Side effects and complications in the use of drugs: hypoglycemia (cold Physician's Drug Reference pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, Central Venous Catheter nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary Cyclic Adenosine Monophosphate permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), Upper Airway Obstruction AR - large skin rash , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change Extracellular fluid injections, they may develop lipodystrophy. Contraindications to the use component products drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. Side effects and complications in the use of drugs: hypoglycemia component products glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and the appearance of blisters, which component products spread beyond the area injection, severe sensitivity reactions to the ingredients. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was component products same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually, depending on metabolism, the selection of dose for Intelligence Quotient is proposed to start with single doses in the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses component products than 8 units, while reducing sensitivity to component products effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / component products insulin Swine component products as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment - changing the appearance of component products at the injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. ' Serum Glutamic Pyruvic Transaminase and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in component products the initial dose should be guided by the level of here and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first component products prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in Hemoglobin trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow start and significant duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the Blood Alcohol Level is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, it depends on the dose and the individual characteristics of the patient component products . component products group: A10AS01 - antidiabetic agent. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy.
Subscribe to:
Posts (Atom)